John Bernard Payne, President and CEO at Zivo Bioscience, Inc. (ZIVO), bought 11,709 shares at $8.54 ($100K) on 2026-01-26, disclosed to the SEC on 2026-01-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| ZIVO | BUY | 2022-01-28 | $23K | — | Filing → |